Пређи на садржај

Онкологија

Интраоперативна примена аутологене крви

Спасавање крви

Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: A systematic review and meta-analysis. (отвара нови прозор)

Aijtink VJ, Rutten VC, Meijer B, de Jong R, Isaac J, Polak W, Perera M, Sneiders D, Hartog H

Извор‎: Ann Surg. 2022;276(2):239-45. 

Индекс‎: PubMed 36036990

DOI‎: 10.1097/SLA.0000000000005476

https://pubmed.ncbi.nlm.nih.gov/36036990/ (отвара нови прозор)

Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. (отвара нови прозор)

Akbulut S, Kayaalp C, Yilmaz M, Ince V, Ozgor D, Karabulut K, Eris C, Toprak HI, Aydin C, Yilmaz S.

Извор‎: World J Gastroenterol 2013;19(10):1625-31.

Индекс‎: PubMed 23538988

DOI‎: 10.3748/wjg.v19.i10.1625

https://www.ncbi.nlm.nih.gov/pubmed/23538988 (отвара нови прозор)

Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? (отвара нови прозор)

Araujo RL, Pantanali CA, Haddad L, Rocha Filho JA, D'Albuquerque LA, Andraus W.

Извор‎: World J Gastrointest Surg 2016;8(2):161-8.

Индекс‎: PubMed 26981190

DOI‎: 10.4240/wjgs.v8.i2.161

https://www.ncbi.nlm.nih.gov/pubmed/26981190 (отвара нови прозор)

Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. (отвара нови прозор)

Bower MR, Ellis SF, Scoggins CR, McMasters KM, Martin RC.

Извор‎: Ann Surg Oncol 2011;18(1):166-73.

Индекс‎: PubMed 21222043

DOI‎: 10.1245/s10434-010-1228-4

https://www.ncbi.nlm.nih.gov/pubmed/21222043 (отвара нови прозор)

Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. (отвара нови прозор)

Gorin MA, Eldefrawy A, Manoharan M, Soloway MS.

Извор‎: World J Urol 2012;30(3):379-83.

Индекс‎: PubMed 21847657

DOI‎: 10.1007/s00345-011-0746-4

https://www.ncbi.nlm.nih.gov/pubmed/21847657 (отвара нови прозор)

Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. (отвара нови прозор)

Han S, Kim G, Ko JS, Sinn DH, Yang JD, Joh JW, Lee SK, Gwak MS.

Извор‎: Ann Surg 2016;264(2):339-43.

Индекс‎: PubMed 26501715

DOI‎: 10.1097/SLA.0000000000001486

https://www.ncbi.nlm.nih.gov/pubmed/26501715 (отвара нови прозор)

Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. (отвара нови прозор)

Kumar N, Chen Y, Zaw AS, Nayak D, Ahmed Q, Soong R, Wong HK.

Извор‎: Lancet Oncol 2014;15(1):e33-41.

Индекс‎: PubMed 24384492

DOI‎: 10.1016/S1470-2045(13)70245-6

https://www.ncbi.nlm.nih.gov/pubmed/24384492 (отвара нови прозор)

Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture? (отвара нови прозор)

Kumar N, Zaw AS, Kantharajanna SB, Khoo BL, Lim CT, Thiery JP

Извор‎: Transfus Med 2017;27 Suppl 5:327-34.

Индекс‎: PubMed 28833768

DOI‎: 10.1111/tme.12453

https://www.ncbi.nlm.nih.gov/pubmed/28833768 (отвара нови прозор)

The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. (отвара нови прозор)

Mirhashemi R, Averette HE, Deepika K, Estape R, Angioli R, Martin J, Rodriguez M, Penalver MA.

Извор‎: Am J Obstet Gynecol 1999;181(6):1310-5.

Индекс‎: PubMed 10601905

https://www.ncbi.nlm.nih.gov/pubmed/10601905 (отвара нови прозор)

Intraoperative cell salvage during radical cystectomy does not affect long-term survival. (отвара нови прозор)

Nieder AM, Manoharan M, Yang Y, Soloway MS.

Извор‎: Urology 2007;69(5):881-4.

Индекс‎: PubMed 17482926

DOI‎: 10.1016/j.urology.2007.01.060

https://www.ncbi.nlm.nih.gov/pubmed/17482926 (отвара нови прозор)

Should intraoperative cell-salvaged blood be used in patients with suspected or known malignancy? (отвара нови прозор)

Trudeau JD, Waters T, Chipperfield K.

Извор‎: Can J Anaesth 2012;59(11):1058-70.

Индекс‎: PubMed 22996966

DOI‎: 10.1007/s12630-012-9781-x

https://www.ncbi.nlm.nih.gov/pubmed/22996966 (отвара нови прозор)

Blood salvage and cancer surgery: a meta-analysis of available studies. (отвара нови прозор)

Waters JH, Yazer M, Chen YF, Kloke J.

Извор‎: Transfusion 2012;52(10):2167-73.

Индекс‎: PubMed 22321196

DOI‎: 10.1111/j.1537-2995.2011.03555.x

https://www.ncbi.nlm.nih.gov/pubmed/22321196 (отвара нови прозор)

Акутна нормоволемијска хемодилуција

Cerebral effect of acute normovolemic hemodilution during brain tumor resection. (отвара нови прозор)

Daif AA, Hassan YM, Ghareeb NA, Othman MM, Mohamed SA.

Извор‎: J Neurosurg Anesthesiol 2012;24(1):19-24.

Индекс‎: PubMed 21904221

DOI‎: 10.1097/ANA.0b013e31822f0346

https://www.ncbi.nlm.nih.gov/pubmed/21904221 (отвара нови прозор)

Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery. (отвара нови прозор)

Habler O, Schwenzer K, Zimmer K, Prager M, König U, Oppenrieder K, Pape A, Steinkraus E, Reither A, Buchrot A, Zwissler B.

Извор‎: Int J Oral Maxillofac Surg 2004;33(5):467-75.

Индекс‎: PubMed 15183411

DOI‎: 10.1016/j.ijom.2003.10.007

https://www.ncbi.nlm.nih.gov/pubmed/15183411 (отвара нови прозор)

A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. (отвара нови прозор)

Jarnagin WR, Gonen M, Maithel SK, Fong Y, D'Angelica MI, Dematteo RP, Grant F, Wuest D, Kundu K, Blumgart LH, Fischer M.

Извор‎: Ann Surg 2008;248(3):360-9.

Индекс‎: PubMed 18791356

DOI‎: 10.1097/SLA.0b013e318184db08

https://www.ncbi.nlm.nih.gov/pubmed/18791356 (отвара нови прозор)